Australia markets closed

MediWound Ltd. (MDWD)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
14.98-0.63 (-4.04%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 139.07M
Enterprise value 109.97M
Trailing P/E 27.07
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.96
Price/book (mrq)5.99
Enterprise value/revenue 5.54
Enterprise value/EBITDA -6.32

Trading information

Stock price history

Beta (5Y monthly) 0.73
52-week change 342.53%
S&P500 52-week change 323.76%
52-week high 319.86
52-week low 37.10
50-day moving average 317.03
200-day moving average 312.51

Share statistics

Avg vol (3-month) 370.26k
Avg vol (10-day) 344.23k
Shares outstanding 59.28M
Implied shares outstanding 69.28M
Float 85.82M
% held by insiders 126.30%
% held by institutions 131.14%
Shares short (15 May 2024) 4232.89k
Short ratio (15 May 2024) 43.37
Short % of float (15 May 2024) 42.93%
Short % of shares outstanding (15 May 2024) 42.45%
Shares short (prior month 15 Apr 2024) 4171.63k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:7
Last split date 320 Dec 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -64.24%
Operating margin (ttm)-75.22%

Management effectiveness

Return on assets (ttm)-14.19%
Return on equity (ttm)-45.14%

Income statement

Revenue (ttm)19.85M
Revenue per share (ttm)2.15
Quarterly revenue growth (yoy)30.70%
Gross profit (ttm)N/A
EBITDA -14.07M
Net income avi to common (ttm)-12.75M
Diluted EPS (ttm)-1.36
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)35.57M
Total cash per share (mrq)3.85
Total debt (mrq)6.47M
Total debt/equity (mrq)27.88%
Current ratio (mrq)1.98
Book value per share (mrq)2.51

Cash flow statement

Operating cash flow (ttm)-15.72M
Levered free cash flow (ttm)-5.7M